CAI
Financials
- Market Capitalization 7.28 B
- Employee 1 846
- Founded 2008
- CEO N/A
- Website www.carislifesciences.com
- Headquarter Texas, United States
- FIGI BBG00255V2N4
- Industry Medical Care Facilities
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 918 |  UHS Universal Health Services, Inc. Common Stock | 171.07 USD | -0.93% | -3.24% | +2.44% | -19.30% | 10.08 B USD | ||
| 920 |  ENSG The Ensign Group, Inc. - Common Stock | 172.82 USD | -0.41% | -3.86% | -5.47% | -0.27% | 10.07 B USD | ||
| 1127 |  PACS PACS Group, Inc. Common Stock | 43.19 USD | -2.42% | -1.35% | -8.96% | +236.24% | 6.84 B USD | ||
| 1135 |  CHE Chemed Corp | 524.27 USD | +0.88% | -2.73% | -0.05% | +14.30% | 6.85 B USD |
Frequently asked questions about Caris Life Sciences, Inc. Common Stock
What is the Caris Life Sciences, Inc. Common Stock stock price today?
The current price of Caris Life Sciences, Inc. Common Stock (CAI) is 25.75. Over the past 24 hours, the stock has changed by -2.39%. Follow the CAI chart for real-time price dynamics.
What is the stock ticker of Caris Life Sciences, Inc. Common Stock?
Caris Life Sciences, Inc. Common Stock trades under the ticker CAI. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Caris Life Sciences, Inc. Common Stock stock going up?
CAI has changed by +0.66% over the last week, +66.88% over the last month, and -32.70% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Caris Life Sciences, Inc. Common Stock?
Caris Life Sciences, Inc. Common Stock currently has a market capitalization of 7.28 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
Does Caris Life Sciences, Inc. Common Stock release financial reports?
Yes. You can track Caris Life Sciences, Inc. Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What were Caris Life Sciences, Inc. Common Stock earnings last quarter?
Last quarter, Caris Life Sciences, Inc. Common Stock reported earnings of 0 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Caris Life Sciences, Inc. Common Stock revenue for the last quarter?
Caris Life Sciences, Inc. Common Stock reported quarterly revenue of 263.71 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Caris Life Sciences, Inc. Common Stock net income for the last quarter?
Caris Life Sciences, Inc. Common Stock reported net income of -637 K for the last quarter. The previous quarter showed -510 K, which means net income changed by -24.90%.
How many employees does Caris Life Sciences, Inc. Common Stock have?
As of the latest available data, Caris Life Sciences, Inc. Common Stock has 1 846 employees. Workforce size can provide additional context about the company's scale and operations.
What is Caris Life Sciences, Inc. Common Stock EBITDA?
Caris Life Sciences, Inc. Common Stock EBITDA is 33.43 M, and its EBITDA margin is 12.68%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Caris Life Sciences, Inc. Common Stock stock?
You can buy Caris Life Sciences, Inc. Common Stock (CAI) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Caris Life Sciences, Inc. Common Stock stock?
Investing in Caris Life Sciences, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CAI chart and related analysis on metatrader.com as part of your research.